With a market cap of $32.6 billion, San Diego, California-based ResMed Inc. (RMD) is a global leader in designing, ...

Morgan Stanley began coverage on shares of ResMed (NYSE:RMD – Free Report) in a research note issued to investors on Wednesday, MarketBeat reports. The firm issued an overweight rating and a $280.00 ...

Independent Advisor Alliance acquired a new stake in shares of ResMed Inc. (NYSE:RMD – Free Report) during the fourth quarter ...

ResMed has launched a rebrand to unify its portfolio and reflect its increasing direct-to-consumer engagement.

Morgan Stanley initiated coverage of ResMed (RMD) with an Overweight rating and A$313 price target The company has a market-leading position ...

Shares of ResMed Inc. RMD shed 2.00% to $220.25 Tuesday, on what proved to be an all-around dismal trading session for the ...

Resmed (NYSE: RMD) announced today that it began a comprehensive brand evolution to unify its brand portfolio.

SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced a ...

Despite good sleep being essential for our overall health, productivity, and relationships, millions worldwide struggle with ...

Companies valued at $10 billion or more are generally classified as “large-cap” stocks, and ResMed fits this criterion perfectly. The company operates through two segments - Sleep and ...

https://www.tipranks.com/news/the-fly/resmed-initiated-with-an-overweight-at-morgan-stanley-2 Morgan Stanley analyst David Bailey initiated coverage of ResMed (RMD ...